Mikael Dolsten insider trades

Open-market stock purchases and sales by Mikael Dolsten, Director at Agilent Technologies, Inc, from SEC Form 4 filings since Feb 25, 2010.

Recent trades

DateStockTradeValue
Sep 4, 2026A Agilent Technologies, IncSold$96K
May 29, 2026A Agilent Technologies, IncSold$217K
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)$506K
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)—
Mar 19, 2026A Agilent Technologies, IncBought (not open market)$241K
Feb 27, 2026APLS Apellis Pharmaceuticals, IncBought (not open market)—
Feb 27, 2026APLS Apellis Pharmaceuticals, IncBought (not open market)$506K
Dec 1, 2025A Agilent Technologies, IncSold$390K

Companies traded

  • A Agilent Technologies, Inc: 3 sales, last Sep 4, 2026
  • APLS Apellis Pharmaceuticals, Inc: other filings, last May 14, 2026
  • RCKT Rocket Pharmaceuticals, Inc: other filings, last Jun 18, 2025
  • PFE Pfizer Inc: 68 sales, last Sep 12, 2024
  • KPTI Karyopharm Therapeutics Inc: other filings, last May 21, 2021

Get free alerts when Mikael Dolsten files a new trade →